Omnicell, Inc. · NASDAQ:OMCL
Omnicell — Merger or Acquisition (January 2022)
7 slides from Omnicell's merger presentation, Jan 4, 2022
Slide 1: MarkeTouch Media
MarkeTouch Media January 4, 2022
Slide 2: Safe Harbor Statement
Safe Harbor Statement 2© 2022 Omnicell, Inc. Content is confidential and proprietary. This presentation contains forward-looking statements that involve risks and uncertainties, including statements regarding the outcome of the acquisition, the expected benefits of the acquisition of the MarkeTouch
Slide 3: Compelling Strategic Benefits
Compelling Strategic Benefits 3© 2022 Omnicell, Inc. Content is confidential and proprietary. Assists health systems in providing specialty pharmacy services to patients, designed to improve continuity of care and patient outcomes Brings mobile and web-based solutions to the EnlivenHealth platform H
Slide 4: Business at a Glance
MarkeTouch Media Business at a Glance 4© 2022 Omnicell, Inc. Content is confidential and proprietary. We believe MarkeTouch Media has a compelling offering for patient engagement, clinical support and pharmacy workflow management designed to accelerate the transformation of both the practice and bus
Slide 5: Accelerates EnlivenHealth's Digital Roadmap and Expands Industry Footprint
MarkeTouch Media Accelerates EnlivenHealth’s Digital Roadmap and Expands Industry Footprint 5© 2022 Omnicell, Inc. Content is confidential and proprietary. Enables us to offer one of the industry’s most comprehensive suites of SaaS technology solutions that are designed to help retail pharmacies and
Slide 6: Transaction Overview
Transaction Overview 6© 2022 Omnicell, Inc. Content is confidential and proprietary. $82 million in cash, subject to customary adjustments Cash on hand Transaction Consideration Earnings Impact and Returns Sources of Financing Anticipated high growth SaaS services business with recurring revenue Exp
Slide 7: Slide 7